ANALYSIS OF SURVIVABILITY OF PATIENTS WITH RECTAL CANCER AFTER EXPERT CARE 

Myasnikov Dmitriy Vladimirovich, Surgeon, Regional oncological dispensary (37a Stroiteley avenue, Penza, Russia), d.v.myasnikov@gmail.com
Nesterov Andrey Vladimirovich, Candidate of medical sciences, associate professor, sub-department of surgery, Medical Institute, Penza State University (40 Krasnaya street, Penza, Russia); deputy chief physician on surgical care, Penza region clinical hospital named after N. N. Burdenko (28 Lermontova street, Penza, Russia), andrnest@mail.ru
Nikishin Dmitriy Viktorovich, Candidate of medical sciences, associate professor, sub-department of human anatomy, Medical Institute, Penza State University (40 Krasnaya street, Penza, Russia), nikishindv@gmail.com
Gudoshnikov Vyacheslav Yur'evich, Candidate of medical sciences, head of abdominal surgery unit, Regional
oncological dispensary (37a Stroiteley avenue, Penza, Russia), d.v.myasnikov@gmail.com
Li Valentina Vyacheslavovna, Practitioner-methodologist, abdominal surgery unit, Regional oncological dispensary (37a Stroiteley avenue, Penza, Russia), d.v.myasnikov@gmail.com

616.089.06-07

Background. On the basis of a retrospective analysis of medical histories the authors are to reveal the average life span of patients after expert care.
Materials and methods. The study is based on the analysis of the results of radical surgical treatment of rectal cancer in 253 patients. All treatments were carried out during the period from 01.01.2005 to 31.12.2013 on the basis of separation of abdominal surgery in Penza regional oncologic dispensary. All the patients depending on the morphological structure of the tumor were divided into three groups.
Results. It was found that the largest were the groups of patients with moderately and highly differentiated adenocarcinoma, 126 (49,8 %) and 78 (30,8 %) respectively. In group 1 – the highest number of patients had stage I rectal cancer, groups 2, 3 – stage II. The study of treatment results was carried out in subgroups defined depending on the type of treatment (only operative, operative in combination with chemotherapy, operative in combination with radiation therapy, operative in combination with chemotherapy and radiation therapy ).
Conclusions. It was found that the best results of 1- and 3-years survival rates were obtained in patients with high-grade adenocarcinoma in those subgroups where complex treatment (surgery, radiotherapy, chemotherapy) was applied.

rectal cancer, surgical treatment, adenocarcinoma.

1. Aksel' E. M., Ushakova T. I. Novoe v terapii kolorektal'nogo raka [The new in colorectal cancer treatment]. Moscow, 2001, 156 p.
2. Trapeznikov N. N., Aksel' E. M. Zabolevaemost' zlokachestvennymi novoobrazovaniyami i smertnost' ot nikh naseleniya SNG [Malignant neoplasms morbidity and mortality among the Commonwealth population]. Moscow, 2000, 268 p.
3. Starinskiy V. V., Remennik L. V., Kharchenko I. V., Mokina V. D. Rossiyskiy onkologicheskiy zhurnal [Russian oncological journal]. 1998, no. 6, pp. 4–9.
4. Fedorov V. D. Rak pryamoy kishki [Rectal cancer]. Moscow, 1987, 320 p.
5. Vashakmadze L. A., Khomyakov V. I., Sidorov D. V. Rossiyskiy onkologicheskiy zhurnal [Russian concological journal]. 1999, no. 6, pp. 47–54.
6. Knysh V. I. Rak obodochnoy i pryamoy kishki [Colorectal cancer]. Moscow, 1997, 95 p.
7. Jatzko G. R., Jagoditsch M., Lisborg P. H. et al. Eur. J. Surg. Oncol. 1999, no. 25, pp. 284–291.
8. Koca D., Binicier C., Oztop I. et al. J. BUON. 2012, vol. 17, no. 2, pp. 291–298.